Performance of AXSM Axsome Therapeutics | 4.1% in 12m
Compare AXSM with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Axsome Therapeutics with its related Sector/Index XLV
Performance Duell AXSM vs XLV
| TimeFrame | AXSM | XLV |
|---|---|---|
| 1 Day | -0.93% | -0.07% |
| 1 Week | 3.73% | 0.40% |
| 1 Month | -0.50% | -2.57% |
| 3 Months | -20.1% | -0.71% |
| 6 Months | 15.2% | 11.70% |
| 12 Months | 4.08% | 6.84% |
| YTD | -3.72% | 1.59% |
| Rel. Perf. 1m | 0.20 | |
| Rel. Perf. 3m | -0.37 | |
| Rel. Perf. 6m | 0.51 | |
| Rel. Perf. 12m | -0.31 |
Is Axsome Therapeutics a good stock to buy?
No, based on ValueRay Fundamental Analyses, Axsome Therapeutics (NASDAQ:AXSM) is currently (May 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -53.23 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AXSM as of May 2024 is 69.31. This means that AXSM is currently overvalued and has a potential downside of -6.58% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AXSM as of May 2024 is 69.31. This means that AXSM is currently overvalued and has a potential downside of -6.58% (Sold with Premium).
Is AXSM a buy, sell or hold?
- Strong Buy: 11
- Buy: 3
- Hold: 2
- Sell: 0
- Strong Sell: 0
Values above 0%: AXSM is performing better - Values below 0%: AXSM is underperforming
Compare AXSM with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 3.42% | 2.16% | -2.88% | -20.63% |
| US NASDAQ 100 | QQQ | 3.15% | 2.72% | -2.71% | -30.48% |
| US Dow Jones Industrial 30 | DIA | 3.39% | 1.85% | 1.19% | -11.58% |
| German DAX 40 | DBXD | 3.92% | 1.78% | -2.65% | -9.06% |
| UK FTSE 100 | ISFU | 2.45% | -3.22% | 0.65% | -5.47% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -1.20% | -3.85% | 10.57% | 14.03% |
| Hongkong Hang Seng | HSI | -3.14% | -6.70% | 14.70% | 18.55% |
| Japan Nikkei 225 | EXX7 | 1.37% | 4.86% | 1.33% | -15.72% |
| India NIFTY 50 | INDA | 2.41% | -3.23% | -5.68% | -25.20% |
| Brasil Bovespa | EWZ | 0.58% | 0.22% | 10.87% | -19.30% |
AXSM Axsome Therapeutics vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1.92% | 2.90% | -4.70% | -32.21% |
| Consumer Discretionary | XLY | 2.36% | 1.23% | 2.91% | -17.44% |
| Consumer Staples | XLP | 3.86% | -0.88% | 3.38% | 3.34% |
| Energy | XLE | 7.94% | 3.52% | 7.61% | -14.86% |
| Financial | XLF | 4.76% | 2.40% | -7.21% | -23.30% |
| Health Care | XLV | 3.33% | 2.07% | 3.50% | -2.76% |
| Industrial | XLI | 4.17% | 1.50% | -6.90% | -20.52% |
| Materials | XLB | 4.11% | 3.51% | -0.27% | -9.37% |
| Real Estate | XLRE | 2.91% | 3.87% | 6.24% | 0.60% |
| Technology | XLK | 4.00% | 4.23% | -1.16% | -28.80% |
| Utilities | XLU | 2.31% | -4.34% | 2.88% | 1.23% |
| Aerospace & Defense | XAR | 0.90% | -1.52% | -0.55% | -17.00% |
| Biotech | XBI | -3.71% | 2.08% | -14.24% | -6.74% |
| Homebuilder | XHB | 2.70% | 3.51% | -22.56% | -44.42% |
| Retail | XRT | 3.34% | 4.43% | -5.75% | -16.93% |
Does Axsome Therapeutics outperform its market, is AXSM a Sector Leader?
No, over the last 12 months Axsome Therapeutics (AXSM) made 4.08%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 6.84%.
Over the last 3 months AXSM made -20.07%, while XLV made -0.71%.
No, over the last 12 months Axsome Therapeutics (AXSM) made 4.08%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 6.84%.
Over the last 3 months AXSM made -20.07%, while XLV made -0.71%.
| Period | AXSM | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -0.50% | -2.57% | -2.66% |
| 3 Months | -20.07% | -0.71% | 2.48% |
| 12 Months | 4.08% | 6.84% | 24.71% |